Plain-English translation of NCT05881005 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This study is trying to understand how often people with Cushing's syndrome develop fatty liver disease and liver scarring. Cushing's syndrome causes the body to produce too much cortisol, a hormone that can trigger the liver to store fat. Researchers want to use imaging tests to see how common this problem is and how serious it gets.
We know that excess cortisol can damage the liver, but doctors don't have clear information about how many Cushing's syndrome patients actually develop fatty liver disease or liver scarring. This study exists to fill that gap and help doctors better understand and treat liver complications in people with this rare condition.
You likely qualify if…
You likely don't qualify if…
You will have two types of imaging tests done to look at your liver: an MRI scan and a Fibroscan (ultrasound-based test). These are non-invasive tests that take pictures of your liver to see if there is fat buildup or scarring. The study involves one visit to the hospital where these tests will be performed.
AI-generated summary from trial data · Jul 11, 2026 · Not medical advice
France
Sponsor
University Hospital, Angers
Enrollment target
~100 participants
Started
September 2023
Primary completion
September 2027
Age range
18 Years and older
Last updated on clinicaltrials.gov in July 2026.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Claire BRIET
University Hospital of Anger
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.